Literature DB >> 31264087

Bone metabolism markers and hungry bone syndrome after parathyroidectomy in dialysis patients with secondary hyperparathyroidism.

Yifei Ge1, Guang Yang1, Ningning Wang1, Xiaoming Zha2, Xiangbao Yu1, Huijuan Mao1, Bin Sun1, Ming Zeng1, Bo Zhang1, Changying Xing3.   

Abstract

OBJECTIVE: To explore the short-term variation in bone metabolic markers and the characteristics of hungry bone syndrome (HBS) after parathyroidectomy (PTX) with forearm autotransplantation in uremic patients with secondary hyperparathyroidism (SHPT) and to provide a basis for the pathogenesis, diagnosis and treatment of metabolic bone disease in SHPT.
METHODS: A total of 115 patients with SHPT receiving PTX from July 2015 to December 2017, hospitalized at the First Affiliated Hospital of Nanjing Medical University, were enrolled in our study. We retrospectively analyzed the baseline clinical data, the levels of bone metabolism markers before and on the third day after PTX, and the risk factors predicting HBS.
RESULTS: Preoperative baseline data showed that the levels of bone metabolic markers such as bone metabolism-regulating hormones: iPTH, calcitonin (CT); bone formation markers: phosphatase (ALP), osteocalcin (OC); bone resorption markers: type I collagen cross-linked N-telopeptides (NTX), type I collagen cross-linked C-telopeptides (CTX), tartrate-resistant acid phosphatase 5b (TRAP-5b) were all increased compared to normal levels. The levels of postoperative serum iPTH, CT, CTX and TRAP-5b decreased significantly compared to preoperative levels, while the levels of OC and ALP increased significantly. Of the 115 patients, 101 (87.8%) developed HBS after PTX. High preoperative serum ALP and low preoperative serum calcium level independently predicted the occurrence of HBS. Younger preoperative age, high preoperative serum ALP and iPTH level independently predicted the severity of HBS.
CONCLUSIONS: In severe SHPT, both bone formation and resorption were active, which suggested the presence of high-turnover bone diseases characterized by up-regulation of osteoclasts-osteoblasts functionally coupling activation in the patients. PTX could promote osteoblast activity and reduce osteoclast activity. HBS was common after PTX. Preoperative higher serum ALP and lower calcium were independent predictors of the occurrence of HBS. Younger patients with higher preoperative ALP and PTH may need to closely monitor serum calcium levels and intensive calcium supplementation after PTX.

Entities:  

Keywords:  Bone metabolism markers; Hungry bone syndrome; Parathyroidectomy; Secondary hyperparathyroidism; Uremia

Mesh:

Year:  2019        PMID: 31264087     DOI: 10.1007/s11255-019-02217-y

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  11 in total

1.  Predictors of hyperkalemia after total parathyroidectomy in patients with drug-refractory secondary hyperparathyroidism.

Authors:  Xi Zhu; Zhouting Li; Xiaofang Xia; Xiaomin Zeng; Feng Cheng; Bin Zhou; Yong Wu; Lei Zhu
Journal:  Gland Surg       Date:  2022-04

2.  A predictive risk score to diagnose hypocalcemia after parathyroidectomy in patients with secondary hyperparathyroidism: a 22-year retrospective cohort study.

Authors:  Mattabhorn Phimphilai; Suchada Inya; Worapaka Manosroi
Journal:  Sci Rep       Date:  2022-06-09       Impact factor: 4.996

3.  Serum nuclear factor IB as a novel and noninvasive indicator in the diagnosis of secondary hyperparathyroidism.

Authors:  Jian'gen Yu; Yu Song; Aihua Yang; Xiaoyun Zhang; Lin Li
Journal:  J Clin Lab Anal       Date:  2021-05-15       Impact factor: 2.352

4.  Predictors of early postoperative hypocalcemia in patients with secondary hyperparathyroidism undergoing total parathyroidectomy.

Authors:  Wei Gong; Yaqi Lin; Yu Xie; Zilu Meng; Yudong Wang
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

5.  Risk Factors for Severe Hypocalcemia in Patients with Secondary Hyperparathyroidism after Total Parathyroidectomy.

Authors:  Ping Wen; Lingling Xu; Shasha Zhao; Wei Gan; Dawei Hou; Liang Zhang; Jinlong Cao; Mingxia Xiong; Lei Jiang; Junwei Yang
Journal:  Int J Endocrinol       Date:  2021-04-02       Impact factor: 3.257

6.  Effect of High Dose Active Vitamin D Therapy on the Development of Hypocalcemia After Subtotal Parathyroidectomy in Patients on Chronic Dialysis.

Authors:  Malina Grube; Frank Weber; Anna Lena Kahl; Andreas Kribben; Nils Mülling; Walter Reinhardt
Journal:  Int J Nephrol Renovasc Dis       Date:  2021-11-11

7.  Risk factors for hypocalcemia in dialysis patients with refractory secondary hyperparathyroidism after parathyroidectomy: a meta-analysis.

Authors:  Dan Gao; Yan Lou; Yingchun Cui; Shengmao Liu; Wenpeng Cui; Guangdong Sun
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

8.  Higher one-year achievement rate of serum phosphate associated with lower cardiovascular mortality in hemodialysis patients.

Authors:  Weichen Zhang; Guoxin Ye; Zhaori Bi; Weisheng Chen; Jing Qian; Minmin Zhang; Ding Ding; Mengjing Wang; Jing Chen
Journal:  BMC Nephrol       Date:  2021-12-01       Impact factor: 2.388

9.  Prediction Model of Postoperative Severe Hypocalcemia in Patients with Secondary Hyperparathyroidism Based on Logistic Regression and XGBoost Algorithm.

Authors:  Chao Ding; Yuwen Guo; Qinqin Mo; Jin Ma
Journal:  Comput Math Methods Med       Date:  2022-07-25       Impact factor: 2.809

10.  Incidence of and risk factors for post-parathyroidectomy hungry bone syndrome in patients with secondary hyperparathyroidism.

Authors:  Kittrawee Kritmetapak; Sawinee Kongpetch; Wijittra Chotmongkol; Yutapong Raruenrom; Sakkarn Sangkhamanon; Chatlert Pongchaiyakul
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.